Diligence memo · auto-generated · as of July 2, 2026
CytoLogic Inc
CytoLogic Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
CytoLogic Inc operates in Biotechnology, based in BOULDER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
CytoLogic Inc has raised $979K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $522K on 2011-12-29.
Most recent recorded round closed around 2011-12-29.
Valuation (modeled)modeled
Provath models CytoLogic Inc at approximately $29M (range $278K–$327M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.47× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era. Within the normal band (147% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 40 months.
Last raise 14.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 17% of Biotechnology peers (4293 compared).
Modeled value ranks above 35% of those peers.
Closest niche peers: Hygeia Therapeutics, Inc., Act Biotech Inc, Ikonopedia, LLC, Iquum Inc, Koronis Pharma, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.